Royal Bank of Canada’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Royal Bank of Canada’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-197,167	Closed	-$1.2M	–	7589
2021 Q3	$1.2M	Buy	197,167 +4,703	+2%	+$28.7K	﹤0.01%	3071
2021 Q2	$1.58M	Buy	192,464 +8,963	+5%	+$73.8K	﹤0.01%	2893
2021 Q1	$1.64M	Sell	183,501 -12,376	-6%	-$111K	﹤0.01%	2773
2020 Q4	$2.26M	Sell	195,877 -57,756	-23%	-$666K	﹤0.01%	2411
2020 Q3	$2.64M	Sell	253,633 -7,550	-3%	-$78.6K	﹤0.01%	2132
2020 Q2	$3.43M	Sell	261,183 -63,476	-20%	-$835K	﹤0.01%	1938
2020 Q1	$2.56M	Sell	324,659 -37,537	-10%	-$295K	﹤0.01%	1982
2019 Q4	$7.5M	Sell	362,196 -16,282	-4%	-$337K	﹤0.01%	1556
2019 Q3	$5.19M	Buy	378,478 +21,511	+6%	+$295K	﹤0.01%	1733
2019 Q2	$4.39M	Sell	356,967 -2,344	-0.7%	-$28.8K	﹤0.01%	1836
2019 Q1	$4.48M	Buy	359,311 +8,441	+2%	+$105K	﹤0.01%	1772
2018 Q4	$3.97M	Sell	350,870 -210,546	-38%	-$2.38M	﹤0.01%	1779
2018 Q3	$10.5M	Buy	561,416 +12,114	+2%	+$227K	﹤0.01%	1331
2018 Q2	$14.2M	Sell	549,302 -20,099	-4%	-$520K	0.01%	1101
2018 Q1	$12.8M	Buy	569,401 +416	+0.1%	+$9.32K	0.01%	1168
2017 Q4	$14.2M	Buy	568,985 +112,601	+25%	+$2.82M	0.01%	1134
2017 Q3	$11M	Buy	456,384 +71,819	+19%	+$1.74M	0.01%	1222
2017 Q2	$7.78M	Buy	384,565 +75,148	+24%	+$1.52M	﹤0.01%	1373
2017 Q1	$8.33M	Buy	309,417 +44,362	+17%	+$1.19M	﹤0.01%	1318
2016 Q4	$5.04M	Buy	265,055 +150,507	+131%	+$2.86M	﹤0.01%	1559
2016 Q3	$2.24M	Buy	114,548 +46,490	+68%	+$908K	﹤0.01%	1973
2016 Q2	$1.02M	Buy	68,058 +39,165	+136%	+$586K	﹤0.01%	2532
2016 Q1	$266K	Buy	28,893 +1,566	+6%	+$14.4K	﹤0.01%	3537
2015 Q4	$527K	Sell	27,327 -7,117	-21%	-$137K	﹤0.01%	3093
2015 Q3	$512K	Buy	34,444 +31,978	+1,297%	+$475K	﹤0.01%	2945
2015 Q2	$54K	Buy	2,466 +1,466	+147%	+$32.1K	﹤0.01%	4692
2015 Q1	$23K	Buy	+1,000	New	+$23K	﹤0.01%	4855